Houlihan Lokey, Inc.

NYSE:HLI

Financial - Capital Markets

Financial Services
$139.22 -1.24%

-$1.78 today

Market cap
$9.66B
Beta
0.95
P/E (TTM)
22.0
EPS (TTM)
$6.42
Dividend yield
1.77%
52W Low $133.83High $211.78

Volume 0.57M

Average 0.67M

Financial health

Houlihan Lokey, Inc. financial health

Start with the overall verdict and the rule-based risk checks for HLI, then work through liquidity, debt, balance-sheet quality, and claims on cash.

Financial health snapshot

Not Scored

Current ratio, interest coverage, and debt cushion are built for industrial companies and do not fit a financial company's balance sheet. Use the risk checks below alongside the company's regulatory capital ratios.

Cash & Investments

$888.00M

Total Debt

$0.00

Shareholders' Equity

$2.31B

Debt / Equity

0.2x

Risk checks

2 of 4 flagged

Debt-service, liquidity, and payout checks are skipped for financial companies, whose borrowings and deposits are operating inputs.

  • Tangible equity base

    73.0%

    Passes when: Goodwill and intangibles are below 50% of equity

  • Contained stock compensation

    28.6%

    Passes when: Stock-based compensation is below 20% of operating cash flow

  • Positive equity

    Positive

    Passes when: Shareholders' equity is above zero

  • Limited dilution

    -0.1%/yr

    Passes when: Diluted share count grows less than 2% a year

Financial strength scores

How strong are the fundamentals over time?

Piotroski tests profitability, balance-sheet direction, and efficiency; Altman estimates bankruptcy risk. Compare the current scores with their fiscal-year history.

Financial strength scores

Piotroski F-Score and Altman Z-Score from the latest reported financials

Piotroski F-Score

Average

7 / 9

Nine pass/fail tests of profitability, balance-sheet strength, and efficiency. 8–9 is strong, 0–3 is weak.

Altman Z-Score

Not meaningful

5.56

The Altman model was built for industrial companies; bank and real-estate balance sheets make it unreliable here.

Score history

Piotroski F-Score and Altman Z-Score recalculated from each fiscal year's statements and year-end market value.

Liquidity

Can it meet short-term obligations?

Check whether cash and current assets cover what falls due within a year without depending on fresh financing.

Cash & Equivalents

$837.00M

Q2 2027

3Y -7.5%1Y +12.3%

Quick Ratio

1.4x

Q1 2027

Current Ratio

1.4x

Q1 2027

Cash Ratio

1.0x

Q1 2027

Working capital

How quickly does cash come back?

Receivable, inventory, and payable days show how much cash the operating cycle ties up and whether that is changing.

Working capital and cash conversion

Annual days measures from year-end receivables, inventory, and payables against revenue and cost of revenue.

Leverage

How much debt risk sits on the balance sheet?

Review total borrowings, debt relative to equity and assets, and whether operating profit covers interest costs.

Total Debt

$0.00

Q2 2027

Debt/Equity

0.2x

Q1 2027

Debt/Assets

0.1x

Q1 2027

Interest Coverage

—

Q1 2027

Debt service

Can cash flow carry the debt?

Measure debt against EBITDA and free cash flow, see how much is due within 12 months, and follow debt and cash over time.

Debt service capacity

Can operating cash flow carry the debt, and how much is due soon?

Debt and cash over time

Fiscal-year-end borrowings against liquid assets; net debt below zero means net cash.

Balance sheet cushion

How much room is there if conditions weaken?

Extra cash and investments, and the balance of assets against liabilities, give the company room when trading gets harder.

Long-Term Investments

$0.00

Q2 2027

Assets

$3.98B

Q2 2027

3Y +0.3%1Y +6.9%

Liabilities

$1.56B

Q2 2027

3Y -1.8%1Y +15.2%

Balance sheet quality

Who funds the assets, and how tangible is the equity?

Split the claims on assets between suppliers, lenders, customers, and shareholders, and see how much equity rests on goodwill and intangibles.

Balance sheet quality

Who funds the assets, and how much of the equity is tangible (Q2 2027).

Shareholder claims

What do shareholders take out of the cash?

Dilution, stock-based pay, dividends, and buybacks all draw on cash flow; check whether free cash flow funds them.

Shareholder claims on cash

Dilution, stock-based pay, and whether free cash flow funds what is returned to shareholders.

Diluted shares, yearly change

-0.1%

FY2021–FY2026 compound rate

Stock-based compensation

$201.3M

28.6% of operating cash flow

Dividends paid

$174.04M

FY 2026

Buybacks

$175.43M

FY 2026

Weighted diluted shares outstanding

Competitor health

How does Houlihan Lokey, Inc. compare with peers?

Compare leverage, interest coverage, and liquidity ratios with similar companies.

Competitor Health

Peer financial health comparison

CompanyMarket CapD/ED/AssetsND/EBITDAInt. Cov.QuickCurrentCash

Morgan Stanley

MS:NYSE

$300.71B4.260.3313.670.451.171.170.20

The Goldman Sachs Group, Inc.

GS:NYSE

$264.37B4.880.3418.530.330.830.830.13

UBS Group AG

UBS:NYSE

$147.91B3.950.2211.810.330.420.420.21

Evercore Inc.

EVR:NYSE

$11.26B0.570.22Net cash32.725.805.804.20

Stifel Financial Corp

SF:NYSE

$10.86B0.360.05Net cash1.075.245.242.99

Jefferies Financial Group Inc.

JEF:NYSE

$8.64B2.250.319.050.202.432.430.79

Piper Sandler Companies

PIPR:NYSE

$4.65B0.080.04Net cash79.6422.7522.7519.91

Moelis & Company

MC:NYSE

$4.14B0.470.15Net cash—21.4721.4717.61

Lazard Inc

LAZ:NYSE

$3.95B2.950.522.394.7429.3529.3518.64

PJT Partners Inc.

PJT:NYSE

$3.81B1.340.22Net cash—27.6727.6715.06

Questions

Financial health questions

Common questions about HLI's balance sheet, answered from the reported figures.

Is HLI's balance sheet healthy?

Houlihan Lokey, Inc. (HLI) has a current ratio of 1.44, a quick read on short-term liquidity.

How leveraged is HLI?

Debt to equity is 0.22, which helps judge how much financing risk sits on the balance sheet.